Detalles de la búsqueda
1.
Impact of COVID-19 on patients with metastatic breast cancer: REthink Access to Care and Treatment survey results.
Future Oncol
; : 1-13, 2024 Apr 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-38682677
2.
Trilaciclib plus chemotherapy versus chemotherapy alone in patients with metastatic triple-negative breast cancer: a multicentre, randomised, open-label, phase 2 trial.
Lancet Oncol
; 20(11): 1587-1601, 2019 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-31575503
3.
Balixafortide plus eribulin in HER2-negative metastatic breast cancer: a phase 1, single-arm, dose-escalation trial.
Lancet Oncol
; 19(6): 812-824, 2018 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-29706375
4.
First-line ribociclib plus letrozole in postmenopausal women with HR+ , HER2- advanced breast cancer: Tumor response and pain reduction in the phase 3 MONALEESA-2 trial.
Breast Cancer Res Treat
; 169(3): 469-479, 2018 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-29404806
5.
Prevention of everolimus-related stomatitis in women with hormone receptor-positive, HER2-negative metastatic breast cancer using dexamethasone mouthwash (SWISH): a single-arm, phase 2 trial.
Lancet Oncol
; 18(5): 654-662, 2017 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-28314691
6.
A phase II study of UCN-01 in combination with irinotecan in patients with metastatic triple negative breast cancer.
Breast Cancer Res Treat
; 137(2): 483-92, 2013 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-23242585
7.
Germline BRCA-Mutated HER2-Negative Advanced Breast Cancer: Overcoming Challenges in Genetic Testing and Clinical Considerations When Using Talazoparib.
Clin Breast Cancer
; 23(5): 469-477, 2023 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-37246120
8.
Margetuximab Versus Trastuzumab in Patients With Previously Treated HER2-Positive Advanced Breast Cancer (SOPHIA): Final Overall Survival Results From a Randomized Phase 3 Trial.
J Clin Oncol
; 41(2): 198-205, 2023 01 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-36332179
9.
Trilaciclib Prior to Chemotherapy in Patients with Metastatic Triple-Negative Breast Cancer: Final Efficacy and Subgroup Analysis from a Randomized Phase II Study.
Clin Cancer Res
; 28(4): 629-636, 2022 02 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-34887261
10.
The Phase II MutHER Study of Neratinib Alone and in Combination with Fulvestrant in HER2-Mutated, Non-amplified Metastatic Breast Cancer.
Clin Cancer Res
; 28(7): 1258-1267, 2022 04 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35046057
11.
Matched Whole-Genome Sequencing (WGS) and Whole-Exome Sequencing (WES) of Tumor Tissue with Circulating Tumor DNA (ctDNA) Analysis: Complementary Modalities in Clinical Practice.
Cancers (Basel)
; 11(9)2019 Sep 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-31546879
12.
Correlation of Somatic Genomic Alterations Between Tissue Genomics and ctDNA Employing Next-Generation Sequencing: Analysis of Lung and Gastrointestinal Cancers.
Mol Cancer Ther
; 17(5): 1123-1132, 2018 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-29500272
13.
Ral signaling pathway in health and cancer.
Cancer Med
; 6(12): 2998-3013, 2017 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-29047224
14.
Neratinib Efficacy and Circulating Tumor DNA Detection of HER2 Mutations in HER2 Nonamplified Metastatic Breast Cancer.
Clin Cancer Res
; 23(19): 5687-5695, 2017 Oct 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28679771
15.
Impact of the addition of carboplatin and/or bevacizumab to neoadjuvant once-per-week paclitaxel followed by dose-dense doxorubicin and cyclophosphamide on pathologic complete response rates in stage II to III triple-negative breast cancer: CALGB 40603 (Alliance).
J Clin Oncol
; 33(1): 13-21, 2015 Jan 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-25092775
16.
A randomized phase II trial investigating the effect of platelet function inhibition on circulating tumor cells in patients with metastatic breast cancer.
Clin Breast Cancer
; 13(6): 409-15, 2013 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-24267729
17.
Ezh2, a novel target in detection and therapy of breast cancer.
Onco Targets Ther
; 10: 2685-2687, 2017.
Artículo
en Inglés
| MEDLINE | ID: mdl-28579806
18.
A Phase 1 study of UCN-01 in combination with irinotecan in patients with resistant solid tumor malignancies.
Cancer Chemother Pharmacol
; 67(6): 1225-37, 2011 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-20694727
Resultados
1 -
18
de 18
1
Próxima >
>>